UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
FNCH holding history
Finch Therapeutics Group, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FNCH overviewAll 13F holders of FNCHFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −110−100.0% | Sold out | Holders |
| Q1 2024 | 110 | $286 | <0.1% | +108+5,400.0% | Added | Holders |
| Q4 2023 | 2 | $7 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2 | $10 | <0.1% | −541−99.6% | Reduced | Holders |
| Q2 2023 | 543 | $4.63K | <0.1% | +541+25,757.1% | AddedConverted for a 1-for-30 split | Holders |
| Q1 2023 | 63 | $25 | <0.1% | −160−71.7% | Reduced | Holders |
| Q4 2022 | 223 | $107 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 223 | $0 | 0.0% | −3,357−93.8% | Reduced | Holders |
| Q2 2022 | 3,580 | $11.0K | <0.1% | +2,376+197.3% | Added | Holders |
| Q1 2022 | 1,204 | $6.00K | <0.1% | −3,986−76.8% | Reduced | Holders |
| Q4 2021 | 5,190 | $52.0K | <0.1% | +3,599+226.2% | Added | Holders |
| Q3 2021 | 1,591 | $21.0K | <0.1% | +893+127.9% | Added | Holders |
| Q2 2021 | 698 | $10.0K | <0.1% | +698 | New | Holders |